fMRI exploration of a biased agonist of 5-HT1A receptors to treat levodopa-induced dyskinesia in hemiparkinsonian rats

被引:0
作者
Chaib, S. [1 ]
Vidal, B. [1 ]
Newman-Tancredi, A. [2 ]
Levigoureux, E. [3 ]
Zimmer, L. [1 ]
机构
[1] Univ Claude Bernard Lyon 1, Univ Lyon, Lyon Neurosci Res Ctr, CNRS,UMR 5292,INSERM,U1028, Lyon, France
[2] Neurolixis Inc, Castres, France
[3] Hosp Civils Lyon, Lyon, France
关键词
5-HT1A receptors; biased agonist; fMRI; functional connectivity; L-DOPA induced dyskinesia; DOPA-INDUCED DYSKINESIA;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CO-024
引用
收藏
页码:22 / 22
页数:1
相关论文
共 31 条
  • [1] A novel biased agonist of 5-HT1A receptors to treat Levodopa-induced dyskinesia? Exploration of the antidyskinetic effects of NLX-112, using [18F]FDG-PET in hemiparkinsonian rats
    Chaib, S.
    Bouillot, C.
    Vidal, B.
    Newman-Tancredi, A.
    Zimmer, L.
    Levigoureux, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 121 - 122
  • [2] 5-HT1A agonists for levodopa-induced dyskinesia in Parkinson's disease
    Al-Kassmy, Jawad
    Sun, Christine
    Huot, Philippe
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2023, 13 (02) : 101 - 112
  • [3] Effects of 5-HT1A Receptor Stimulation on D1 Receptor Agonist-Induced Striatonigral Activity and Dyskinesia in Hemiparkinsonian Rats
    Dupre, Kristin B.
    Ostock, Corinne Y.
    George, Jessica A.
    Jaunarajs, Karen L. Eskow
    Hueston, Cara M.
    Bishop, Christopher
    ACS CHEMICAL NEUROSCIENCE, 2013, 4 (05): : 747 - 760
  • [4] Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats
    Shi, Hongjuan
    Yang, Xinxin
    Zhao, Hui
    Zhang, Shenyang
    Zu, Jie
    Zhang, Wei
    Shen, Xia
    Cui, Guiyun
    Hua, Fang
    Yan, Chuanzhu
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1331 - 1337
  • [5] Different Alterations of Agonist and Antagonist Binding to 5-HT1A Receptor in a Rat Model of Parkinson's Disease and Levodopa-Induced Dyskinesia: A MicroPET Study
    Vidal, Benjamin
    Levigoureux, Elise
    Chaib, Sarah
    Bouillot, Caroline
    Billard, Thierry
    Newman-Tancredi, Adrian
    Zimmer, Luc
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (03) : 1257 - 1269
  • [6] Multimodal imaging study of the 5-HT1A receptor biased agonist, NLX-112, in a model of L-DOPA-induced dyskinesia
    Chaib, Sarah
    Vidal, Benjamin
    Bouillot, Caroline
    Depoortere, Ronan
    Newman-Tancredi, Adrian
    Zimmer, Luc
    Levigoureux, Elise
    NEUROIMAGE-CLINICAL, 2023, 39
  • [7] Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats
    Steece-Collier, Kathy
    Collier, Timothy J.
    Lipton, Jack W.
    Stancati, Jennifer A.
    Winn, Mary E.
    Cole-Strauss, Allyson
    Sellnow, Rhyomi
    Conti, Melissa M.
    Mercado, Natosha M.
    Nillni, Eduardo A.
    Sortwell, Caryl E.
    Manfredsson, Fredric P.
    Bishop, Christopher
    EXPERIMENTAL NEUROLOGY, 2020, 330
  • [8] Activity of serotonin 5-HT1A receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia
    Iderberg, H.
    McCreary, A. C.
    Varney, M. A.
    Cenci, M. A.
    Newman-Tancredi, A.
    NEUROPHARMACOLOGY, 2015, 93 : 52 - 67
  • [9] Modulating mGluR5 and 5-HT1A/1B receptors to treat L-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action
    Iderberg, Hanna
    Rylander, Daniella
    Bimpisidis, Zisis
    Cenci, M. Angela
    EXPERIMENTAL NEUROLOGY, 2013, 250 : 116 - 124
  • [10] Simultaneous PET/MR Imaging for the Exploration of Serotonin 5-HT1A Receptor Biased Agonists
    Vidal, Benjamin
    Fieux, Sylvain
    Redoute, Jerome
    Le Bars, Didier
    Newman-Tancredi, Adrian
    Costes, Nicolas
    Zimmer, Luc
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S581 - S581